RT Journal Article
T1 Selective estrogen receptor modulators as brain therapeutic agents
A1 Arévalo, Maria Ángeles
A1 Santos-Galindo, Maria
A1 Lagunas García, Luisa Natalia
A1 Azcoitia Elías, Íñigo
A1 Luis M. Garcia-Segura, 
AB Selective estrogen receptor modulators (SERMs), used for the treatment of breast cancer, osteoporosis, and menopausal symptoms, affect the nervous system. Some SERMs trigger neuroprotective mechanisms and reduce neural damage in different experimental models of neural trauma, brain inflammation, neurodegenerative diseases, cognitive impairment, and affective disorders. New SERMs with specific actions on neurons and glial cells may represent promising therapeutic tools for the brain.
PB BioScientifica
SN 0952-5041
SN 1479-6813
YR 2010
FD 2010
LK https://hdl.handle.net/20.500.14352/95498
UL https://hdl.handle.net/20.500.14352/95498
LA eng
NO Arevalo MA, Santos-Galindo M, Lagunas N, Azcoitia I, Garcia-Segura LM. Selective estrogen receptor modulators as brain therapeutic agents. J Mol Endocrinol. 2011 Jan 19;46(1):R1-9. doi: 10.1677/JME-10-0122. PMID: 21071476.
DS Docta Complutense
RD 7 abr 2025